市場調查報告書
商品編碼
1535147
PTA 球囊導管市場:依細分市場劃分的規模、佔有率、法規、償付、程序、到2033年的預測PTA Balloon Catheters Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
PTA 球囊導管是一種球囊,插入受影響的動脈並充氣,將斑塊推向動脈壁,擴寬動脈並改善血流。導管透過皮膚上的小切口插入動脈,並使用 X 光和超音波等影像技術引導至阻塞處。
使用標準 PTA 球囊導管的微創技術治療週邊動脈疾病(PAD),該技術用於打開因斑塊堆積(動脈粥狀硬化)而阻塞的動脈。 PTA 週邊 DEB 導管是一種藥物塗層經皮腔內血管成形術(PTA)球囊,目的是預防週邊動脈再狹窄。
本報告深入探討了全球 PTA 球囊導管市場,包括競爭格局、SWOT 分析、到2033年的市場預測以及區域和國家趨勢。
PTA Balloon Catheters Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative and qualitative market trends within Cardiovascular Devices therapeutic area.
A PTA balloon catheter is a type of balloon that is inserted into the affected artery and inflated to push the plaque against the walls of the artery, thus widening the artery and improving blood flow. The catheter is inserted into the artery through a small incision in the skin and guided to the site of the blockage using imaging techniques such as X-ray or ultrasound.
Minimally Invasive technique is used to treat Peripheral artery disease (PAD) with the help of Standard PTA Balloon Catheters that are used to open up the arteries that are blocked by plaque build-up (atherosclerosis). PTA Peripheral DEB Catheter is a drug-coated percutaneous transluminal angioplasty (PTA) balloon intended to prevent restenosis, or restenosis of the peripheral arteries.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed PTA Balloon Catheters and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Becton Dickinson and Co, Medtronic Plc, Boston Scientific Corp, Abbott Laboratories, Koninklijke Philips NV, Shockwave Medical Inc, Cardinal Health Inc, Cook Group Inc, B. Braun Melsungen AG, Terumo Corp, Acotec Scientific Holdings Ltd, Kaneka Corp, Lepu Medical Technology (Beijing) Co Ltd, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -